BSE · DPL
DIPNA PHARMACHEM LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,472
of 5,088 stocks
▼ 581W
Peak #4,414 · 21 Sep 2026
A microcap name in Healthcare, DIPNA PHARMACHEM LIMITED trades at an undemanding earnings multiple, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 9%.
Market Cap
11.46 Cr
P/E Ratio
4.36
P/B Ratio
0.18
ROE
4.22%
ROCE
6.92%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q4 2024-25 |
|---|---|---|
| Revenue | 2.02 Cr | 15.92 Cr |
| Net Profit | 17.86 L | 50.13 L |
| EPS | 0.07 | 0.21 |
| Operating Profit | 45.42 L | 1.28 Cr |
Shareholding pattern
Promoter
9.13%
Public
90.87%
PUBLIC BREAKDOWN
Individuals
84.16%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Feb 2024 | Other | Right Issue of Equity Shares |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.